Avidity-controlled hydrogels for injectable co-delivery of induced pluripotent stem cell-derived endothelial cells and growth factors.

To translate recent advances in induced pluripotent stem cell biology to clinical regenerative medicine therapies, new strategies to control the co-delivery of cells and growth factors are needed. Building on our previous work designing Mixing-Induced Two-Component Hydrogels (MITCHs) from engineered proteins, here we develop protein-polyethylene glycol (PEG) hybrid hydrogels, MITCH-PEG, which form physical gels upon mixing for cell and growth factor co-delivery. MITCH-PEG is a mixture of C7, which is a linear, engineered protein containing seven repeats of the CC43 WW peptide domain (C), and 8-arm star-shaped PEG conjugated with either one or two repeats of a proline-rich peptide to each arm (P1 or P2, respectively). Both 20kDa and 40kDa star-shaped PEG variants were investigated, and all four PEG-peptide variants were able to undergo a sol-gel phase transition when mixed with the linear C7 protein at constant physiological conditions due to noncovalent hetero-dimerization between the C and P domains. Due to the dynamic nature of the C-P physical crosslinks, all four gels were observed to be reversibly shear-thinning and self-healing. The P2 variants exhibited higher storage moduli than the P1 variants, demonstrating the ability to tune the hydrogel bulk properties through a biomimetic peptide-avidity strategy. The 20kDa PEG variants exhibited slower release of encapsulated vascular endothelial growth factor (VEGF), due to a decrease in hydrogel mesh size relative to the 40kDa variants. Human induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) adopted a well-spread morphology within three-dimensional MITCH-PEG cultures, and MITCH-PEG provided significant protection from cell damage during ejection through a fine-gauge syringe needle. In a mouse hindlimb ischemia model of peripheral arterial disease, MITCH-PEG co-delivery of hiPSC-ECs and VEGF was found to reduce inflammation and promote muscle tissue regeneration compared to a saline control.

[1]  D. Cheresh,et al.  Integrins, angiogenesis and vascular cell survival. , 1996, Chemistry & biology.

[2]  D. Wirtz,et al.  Reversible hydrogels from self-assembling artificial proteins. , 1998, Science.

[3]  S. Heilshorn,et al.  Protein‐Engineered Injectable Hydrogel to Improve Retention of Transplanted Adipose‐Derived Stem Cells , 2013, Advanced healthcare materials.

[4]  StefanieDimmeler,et al.  Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis , 2002 .

[5]  S. Prakash,et al.  Recent advancements in tissue engineering for stem cell-based cardiac therapies. , 2013, Therapeutic delivery.

[6]  J. Cooke,et al.  Bioluminescence Imaging of Stem Cell-Based Therapeutics for Vascular Regeneration , 2012, Theranostics.

[7]  R. Kalluri,et al.  Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria* , 2003, The Journal of Biological Chemistry.

[8]  David J. Mooney,et al.  Design of Biodegradable Hydrogel for the Local and Sustained Delivery of Angiogenic Plasmid DNA , 2008, Pharmaceutical Research.

[9]  K. Barylyuk,et al.  Hexameric supramolecular scaffold orients carbohydrates to sense bacteria. , 2011, Journal of the American Chemical Society.

[10]  Byung-Soo Kim,et al.  Active Blood Vessel Formation in the Ischemic Hindlimb Mouse Model Using a Microsphere/Hydrogel Combination System , 2010, Pharmaceutical Research.

[11]  Seungpyo Hong,et al.  The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .

[12]  L. Regan,et al.  Stimuli-responsive smart gels realized via modular protein design. , 2010, Journal of the American Chemical Society.

[13]  J. A. Hubbell,et al.  Cell‐Responsive Synthetic Hydrogels , 2003 .

[14]  Walter H. Stockmayer,et al.  Theory of Molecular Size Distribution and Gel Formation in Branched‐Chain Polymers , 1943 .

[15]  Donald Gullberg,et al.  Integrins , 2009, Cell and Tissue Research.

[16]  A. Avogaro,et al.  Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. , 2010, Atherosclerosis.

[17]  Samuel I Stupp,et al.  Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair , 2011, Proceedings of the National Academy of Sciences.

[18]  Ji Seok Lee,et al.  Two-component protein-engineered physical hydrogels for cell encapsulation , 2009, Proceedings of the National Academy of Sciences.

[19]  Elias T. Zambidis,et al.  Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. , 2013, American journal of translational research.

[20]  Smadar Cohen,et al.  The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. , 2010, Biomaterials.

[21]  J. Michel.  Anoikis in the cardiovascular system: known and unknown extracellular mediators. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Douglas Losordo,et al.  Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. , 2008, Circulation.

[23]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[24]  H. Haider,et al.  Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. , 2008, Journal of molecular and cellular cardiology.

[25]  W. P. Russ,et al.  Natural-like function in artificial WW domains , 2005, Nature.

[26]  Stephanie I. Fraley,et al.  A distinctive role for focal adhesion proteins in three-dimensional cell motility , 2010, Nature Cell Biology.

[27]  H R Hoogenboom,et al.  Design and application of diabodies, triabodies and tetrabodies for cancer targeting. , 2001, Journal of immunological methods.

[28]  J. Hubbell,et al.  Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. , 2003, Biomacromolecules.

[29]  Y. Tabata,et al.  Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia , 2007, Heart and Vessels.

[30]  David J Brayden,et al.  Advances in PEGylation of important biotech molecules: delivery aspects , 2008, Expert opinion on drug delivery.

[31]  Douglas Losordo,et al.  Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. , 2013, Circulation research.

[32]  David J Mooney,et al.  Effects of VEGF temporal and spatial presentation on angiogenesis. , 2010, Biomaterials.

[33]  D. Nochy,et al.  VEGF inhibition and renal thrombotic microangiopathy. , 2008, The New England journal of medicine.

[34]  B. Olsen,et al.  Yielding Behavior in Injectable Hydrogels from Telechelic Proteins. , 2010, Macromolecules.

[35]  Anna Barnard,et al.  Self-assembled multivalency: dynamic ligand arrays for high-affinity binding. , 2012, Angewandte Chemie.

[36]  Ji Seok Lee,et al.  Molecular-level engineering of protein physical hydrogels for predictive sol-gel phase behavior. , 2011, Biomacromolecules.

[37]  J. Pober,et al.  Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  Brian A. Aguado,et al.  Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. , 2012, Tissue engineering. Part A.

[39]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[40]  E Ruoslahti,et al.  Integrin signaling. , 1999, Science.

[41]  Paul J. Flory,et al.  Molecular Size Distribution in Three Dimensional Polymers. II. Trifunctional Branching Units , 1941 .

[42]  Xiaoli Zhang,et al.  A Protein-Based Hydrogel for In Vitro Expansion of Mesenchymal Stem Cells , 2013, PloS one.

[43]  J. Burdick,et al.  Secondary Photocrosslinking of Injectable Shear‐Thinning Dock‐and‐Lock Hydrogels , 2013, Advanced healthcare materials.

[44]  Jason A Burdick,et al.  Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism. , 2012, Biomaterials.

[45]  F. Re,et al.  Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells , 1994, The Journal of cell biology.

[46]  Torsten Blunk,et al.  Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[47]  Kirk Czymmek,et al.  Injectable solid peptide hydrogel as a cell carrier: effects of shear flow on hydrogels and cell payload. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[48]  M. Merchant,et al.  The FASEB Journal • FJ Express Full-Length Article Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia , 2022 .

[49]  D. Lauffenburger,et al.  Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Gavriil Tsechpenakis,et al.  Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia. , 2011, Tissue engineering. Part A.

[51]  Fredrik Höök,et al.  A method improving the accuracy of fluorescence recovery after photobleaching analysis. , 2008, Biophysical journal.

[52]  W. Kao,et al.  Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems , 2010, Expert opinion on drug delivery.

[53]  Sanjiv S Gambhir,et al.  Endothelial Cells Derived From Human iPSCS Increase Capillary Density and Improve Perfusion in a Mouse Model of Peripheral Arterial Disease , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[54]  Y. Hayashizaki,et al.  Reversible hydrogel formation driven by protein-peptide-specific interaction and chondrocyte entrapment. , 2010, Biomaterials.

[55]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[56]  Paul J. Flory,et al.  Molecular Size Distribution in Three Dimensional Polymers. I. Gelation1 , 1941 .